Aptamer Sciences Inc

KOSDAQ:A291650 Stock Report

Market Cap: ₩33.1b

Aptamer Sciences Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Dongil Han

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownership16.5%
Management average tenureno data
Board average tenureno data

Recent management updates

Recent updates

Health Check: How Prudently Does Aptamer Sciences (KOSDAQ:291650) Use Debt?

Jul 26
Health Check: How Prudently Does Aptamer Sciences (KOSDAQ:291650) Use Debt?

Is Aptamer Sciences (KOSDAQ:291650) A Risky Investment?

Mar 26
Is Aptamer Sciences (KOSDAQ:291650) A Risky Investment?

CEO

Dongil Han

no data

Tenure

Dongil Han serves as Chief Executive Officer and Chairman of Aptamer Sciences Inc. Dongil Han was an Executive at POSTECH biotechnology and SK Biopharmaceuticals. Dongil Han was a Team leader in drug devel...